This approach is consistent with what works for managing semaglutide diet protocols and tirzepatide diet plans as well
The two datasets converge on the same point: much of what DXA labels as lean-mass loss on a GLP-1 is liver tissue responding to metabolic disease, not muscle responding to the medication
No sweeteners, no preservatives, just real support
Consistency with dosing and adherence to healthy lifestyle habits are key factors in achieving and maintaining weight loss goals
Moreover, while the OUG defines an off-treatment period as at least 6 months, we defined it as 1 year, taking into account the rate of increase in BMI and other laboratory values after treatment discontinuation, as well as clinical expert opinion
Particles having a size ranging from 340 nm to 850 nm can be produced, scaled-up, characterized and tested